Trial
NCT05126433
Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
Jazz Pharmaceuticals Ireland Limited
Condition
Advanced Solid Tumor
Intervention
Lurbinectedin
Why stopped
Termination of this study was a business decision made during portfolio review.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-28